424 related articles for article (PubMed ID: 27366013)
1. Effect of Hydroxychloroquine Treatment on Dry Eyes in Subjects with Primary Sjögren's Syndrome: a Double-Blind Randomized Control Study.
Yoon CH; Lee HJ; Lee EY; Lee EB; Lee WW; Kim MK; Wee WR
J Korean Med Sci; 2016 Jul; 31(7):1127-35. PubMed ID: 27366013
[TBL] [Abstract][Full Text] [Related]
2. Safety and Efficacy of Oral Hydroxychloroquine in the Treatment of Ophthalmic Disease Associated with Sjögren's Syndrome.
Fang W; Qingqing Z; Qihui L; Bing Z; Xinyue H; Jie X
Altern Ther Health Med; 2023 Nov; 29(8):656-662. PubMed ID: 37678871
[TBL] [Abstract][Full Text] [Related]
3. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.
Wang SQ; Zhang LW; Wei P; Hua H
BMC Musculoskelet Disord; 2017 May; 18(1):186. PubMed ID: 28499370
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Sjögren's syndrome dry eye using 0.03% tacrolimus eye drop: Prospective double-blind randomized study.
Moscovici BK; Holzchuh R; Sakassegawa-Naves FE; Hoshino-Ruiz DR; Albers MB; Santo RM; Hida RY
Cont Lens Anterior Eye; 2015 Oct; 38(5):373-8. PubMed ID: 25956572
[TBL] [Abstract][Full Text] [Related]
5. Hydroxychloroquine improves dry eye symptoms of patients with primary Sjogren's syndrome.
Yavuz S; Asfuroğlu E; Bicakcigil M; Toker E
Rheumatol Int; 2011 Aug; 31(8):1045-9. PubMed ID: 20309693
[TBL] [Abstract][Full Text] [Related]
6. Primary Sjögren's syndrome: Extraglandular manifestations and hydroxychloroquine therapy.
Demarchi J; Papasidero S; Medina MA; Klajn D; Chaparro Del Moral R; Rillo O; Martiré V; Crespo G; Secco A; Catalan Pellet A; Amitrano C; Crow C; Asnal C; Pucci P; Caeiro F; Benzanquen N; Pirola JP; Mayer M; Zazzetti F; Velez S; Barreira J; Tamborenea N; Santiago L; Raiti L
Clin Rheumatol; 2017 Nov; 36(11):2455-2460. PubMed ID: 28913747
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the first tear film break-up point in Sjögren's syndrome and non-Sjögren's syndrome dry eye patients.
Zhao S; Le Q
BMC Ophthalmol; 2022 Jan; 22(1):1. PubMed ID: 34980014
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Efficacy and Safety of A Novel 0.05% Cyclosporin A Topical Nanoemulsion in Primary Sjögren's Syndrome Dry Eye.
Kang MJ; Kim YH; Chou M; Hwang J; Cheon EJ; Lee HJ; Chung SH
Ocul Immunol Inflamm; 2020 Apr; 28(3):370-378. PubMed ID: 30986119
[No Abstract] [Full Text] [Related]
9. Correlation between Tear Osmolarity and Other Ocular Surface Parameters in Primary Sjögren's Syndrome.
Kim M; Kim HS; Na KS
Korean J Ophthalmol; 2017 Feb; 31(1):25-31. PubMed ID: 28243020
[TBL] [Abstract][Full Text] [Related]
10. Analysis of tear cytokines and clinical correlations in Sjögren syndrome dry eye patients and non-Sjögren syndrome dry eye patients.
Lee SY; Han SJ; Nam SM; Yoon SC; Ahn JM; Kim TI; Kim EK; Seo KY
Am J Ophthalmol; 2013 Aug; 156(2):247-253.e1. PubMed ID: 23752063
[TBL] [Abstract][Full Text] [Related]
11. Tear osmolarity measurements in dry eye related to primary Sjögren's syndrome.
Utine CA; Bıçakçıgil M; Yavuz S; Çiftçi F
Curr Eye Res; 2011 Aug; 36(8):683-90. PubMed ID: 21780917
[TBL] [Abstract][Full Text] [Related]
12. IL-14α as a Putative Biomarker for Stratification of Dry Eye in Primary Sjögren's Syndrome.
Liang Y; Xian Z; Fu D; Liu S; Yao Y; Jin Y; Gao C; Shen L; Shi G; He J
Front Immunol; 2021; 12():673658. PubMed ID: 34012457
[TBL] [Abstract][Full Text] [Related]
13. [Autologous serum tears: Long-term treatment in dry eye syndrome].
Beylerian M; Lazaro M; Magalon J; Veran J; Darque A; Grimaud F; Stolowy N; Beylerian H; Sabatier F; Hoffart L
J Fr Ophtalmol; 2018 Mar; 41(3):246-254. PubMed ID: 29602451
[TBL] [Abstract][Full Text] [Related]
14. Effects of hydroxychloroquine on symptomatic improvement in primary Sjögren syndrome: the JOQUER randomized clinical trial.
Gottenberg JE; Ravaud P; Puéchal X; Le Guern V; Sibilia J; Goeb V; Larroche C; Dubost JJ; Rist S; Saraux A; Devauchelle-Pensec V; Morel J; Hayem G; Hatron P; Perdriger A; Sene D; Zarnitsky C; Batouche D; Furlan V; Benessiano J; Perrodeau E; Seror R; Mariette X
JAMA; 2014 Jul; 312(3):249-58. PubMed ID: 25027140
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of platelet-rich plasma and autologous-serum eye drops for dry eye in primary Sjögren's syndrome: a randomized trial.
Kang MJ; Lee JH; Hwang J; Chung SH
Sci Rep; 2023 Nov; 13(1):19279. PubMed ID: 37935760
[TBL] [Abstract][Full Text] [Related]
16. Is Sjögren's syndrome dry eye similar to dry eye caused by other etiologies? Discriminating different diseases by dry eye tests.
Garcia DM; Reis de Oliveira F; Módulo CM; Faustino J; Barbosa AP; Alves M; Rocha EM
PLoS One; 2018; 13(12):e0208420. PubMed ID: 30507949
[TBL] [Abstract][Full Text] [Related]
17. A multi-center, open-label, randomized study to explore efficacy and safety of baricitinib in active primary Sjogren's syndrome patients.
Bai W; Yang F; Xu H; Wei W; Li H; Zhang L; Zhao Y; Shi X; Zhang Y; Zeng X; Leng X
Trials; 2023 Feb; 24(1):112. PubMed ID: 36793118
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjögren's syndrome-related dry eye.
Vitale S; Goodman LA; Reed GF; Smith JA
Health Qual Life Outcomes; 2004 Sep; 2():44. PubMed ID: 15341657
[TBL] [Abstract][Full Text] [Related]
19. Traditional Chinese medicine compound ShengJinRunZaoYangXue granules for treatment of primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled clinical trial.
Hu W; Qian X; Guo F; Zhang M; Lyu C; Tao J; Gao Z; Zhou Z
Chin Med J (Engl); 2014; 127(15):2721-6. PubMed ID: 25146603
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of dry eye syndrome and Sjogren's syndrome in patients with rheumatoid arthritis.
Kosrirukvongs P; Ngowyutagon P; Pusuwan P; Koolvisoot A; Nilganuwong S
J Med Assoc Thai; 2012 Apr; 95 Suppl 4():S61-9. PubMed ID: 22696854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
